JOP20210330A1 - مركبات بيرازولو-بيريدين عطرية غير متجانسة مستبدلة واستخدامها كمعدِّلات لمستقبل الغلوتومات "glun2b" - Google Patents
مركبات بيرازولو-بيريدين عطرية غير متجانسة مستبدلة واستخدامها كمعدِّلات لمستقبل الغلوتومات "glun2b"Info
- Publication number
- JOP20210330A1 JOP20210330A1 JOP/2021/0330A JOP20210330A JOP20210330A1 JO P20210330 A1 JOP20210330 A1 JO P20210330A1 JO P20210330 A JOP20210330 A JO P20210330A JO P20210330 A1 JOP20210330 A1 JO P20210330A1
- Authority
- JO
- Jordan
- Prior art keywords
- pyridines
- pyrazolo
- glun2b receptor
- receptor modulators
- substituted heteroaromatic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Abstract
بيرازول-بيريدينات مستبدلة مثل رابطة مستقبل GluN2B. ويمكن استخدام مثل هذه المركبات في تعديل مستقبلات GluN2B وفي التركيبات الصيدلانية والطرق المتعلقة بعلاج الأمراض والاضطرابات والحالات التي يسببها نشاط مستقبل GluN2B.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962861665P | 2019-06-14 | 2019-06-14 | |
PK34920 | 2020-06-03 | ||
PCT/EP2020/066384 WO2020249785A1 (en) | 2019-06-14 | 2020-06-12 | Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
JOP20210330A1 true JOP20210330A1 (ar) | 2023-01-30 |
Family
ID=73781827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2021/0330A JOP20210330A1 (ar) | 2019-06-14 | 2020-06-12 | مركبات بيرازولو-بيريدين عطرية غير متجانسة مستبدلة واستخدامها كمعدِّلات لمستقبل الغلوتومات "glun2b" |
Country Status (21)
Country | Link |
---|---|
US (2) | US11530210B2 (ar) |
EP (1) | EP3982958A1 (ar) |
JP (1) | JP2022536424A (ar) |
KR (1) | KR20220024512A (ar) |
CN (1) | CN114007610A (ar) |
AU (1) | AU2020291188A1 (ar) |
BR (1) | BR112021025141A2 (ar) |
CA (1) | CA3143276A1 (ar) |
CL (1) | CL2021003257A1 (ar) |
CO (1) | CO2021016860A2 (ar) |
CR (1) | CR20210615A (ar) |
DO (1) | DOP2021000250A (ar) |
EC (1) | ECSP21090450A (ar) |
IL (1) | IL288858A (ar) |
JO (1) | JOP20210330A1 (ar) |
MA (1) | MA56183A (ar) |
MX (1) | MX2021015503A (ar) |
PE (1) | PE20220806A1 (ar) |
SG (1) | SG11202112405VA (ar) |
TW (1) | TW202115054A (ar) |
WO (1) | WO2020249785A1 (ar) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201819376A (zh) | 2016-10-06 | 2018-06-01 | 比利時商健生藥品公司 | 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途 |
US11447503B2 (en) | 2019-06-14 | 2022-09-20 | Janssen Pharmaceutica Nv | Pyridine carbamates and their use as GLUN2B receptor modulators |
PE20220386A1 (es) | 2019-06-14 | 2022-03-18 | Janssen Pharmaceutica Nv | Amidas de pirazolo-piridina sustituidas y su uso como moduladores del receptor glun2b |
EP3983073A1 (en) | 2019-06-14 | 2022-04-20 | Janssen Pharmaceutica NV | Substituted pyrazolo[4,3-b]pyridines and their use as glun2b receptor modulators |
CN114008052A (zh) | 2019-06-14 | 2022-02-01 | 詹森药业有限公司 | 取代的吡唑并-吡嗪以及它们作为GluN2B受体调节剂的用途 |
KR20220020915A (ko) | 2019-06-14 | 2022-02-21 | 얀센 파마슈티카 엔.브이. | GluN2B 수용체 조절제로서의 피라진 카르바메이트 및 이들의 용도 |
EP3982958A1 (en) | 2019-06-14 | 2022-04-20 | Janssen Pharmaceutica NV | Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulators |
CN114149425A (zh) * | 2021-11-16 | 2022-03-08 | 上海应用技术大学 | 5-氟甲基吡啶衍生物和18-f同位素标记的5-氟甲基吡啶衍生物及其制备与应用 |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9407447D0 (en) | 1994-04-14 | 1994-06-08 | Glaxo Group Ltd | Chemical compounds |
DE69730980T2 (de) | 1996-07-31 | 2006-02-23 | Nikken Chemicals Co., Ltd. | 6-phenyltetrahydro-1,3-oxazin-2-on derivate und medizinische zusammensetzungen, die sie enthalten |
AU2001270149A1 (en) | 2000-06-26 | 2002-01-08 | Merck & Co., Inc. | Iminopyrimidine nmda nr2b receptor antagonists |
US6610723B2 (en) | 2001-01-29 | 2003-08-26 | Hoffmann-La Roche Inc. | Imidazole derivatives |
EP1434865A2 (en) | 2001-07-24 | 2004-07-07 | Genset S.A. | Variants and exons of the glyt1 transporter |
JP2005534618A (ja) | 2002-03-28 | 2005-11-17 | エーザイ株式会社 | 神経変性疾患用の、c−junn−末端キナーゼ阻害剤としての7−アザインドール |
US7005432B2 (en) | 2002-05-16 | 2006-02-28 | Hoffman-La Roche Inc. | Substituted imidazol-pyridazine derivatives |
AU2005214375A1 (en) | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Triazole compounds and their use as metabotropic glutamate receptor antagonists |
EP1796673A2 (en) | 2004-09-23 | 2007-06-20 | Reddy US Therapeutics, Inc. | Novel pyrimidine compounds, process for their preparation and compositions containing them |
US7807704B2 (en) | 2006-03-30 | 2010-10-05 | Chemocentryx, Inc. | Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 |
PE20090717A1 (es) | 2007-05-18 | 2009-07-18 | Smithkline Beecham Corp | Derivados de quinolina como inhibidores de la pi3 quinasa |
CN101687790B (zh) | 2007-05-25 | 2015-02-11 | Abbvie公司 | 作为代谢型谷氨酸受体2(mglu2受体)的正向调节剂的杂环化合物 |
WO2009004430A1 (en) | 2007-06-29 | 2009-01-08 | Pfizer Inc. | N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors |
MX2010002266A (es) | 2007-08-30 | 2010-03-25 | Takeda Pharmaceutical | Derivados de pirazol sustituidos. |
US20100249164A1 (en) | 2007-10-31 | 2010-09-30 | Renger John J | Modulation of sleep with nr2b receptor antagonists |
WO2009118187A1 (en) | 2008-03-27 | 2009-10-01 | Evotec Neurosciences Gmbh | Methods for treating disorders using nmda nr2b-subtype selective antagonist |
US20110130384A1 (en) | 2008-06-25 | 2011-06-02 | Takeda Pharmaceutical Company Limited | Amide compound |
PT2308877E (pt) | 2008-08-05 | 2014-05-02 | Daiichi Sankyo Co Ltd | Derivados de imidazopiridin-2-ona |
US9643922B2 (en) | 2008-08-18 | 2017-05-09 | Yale University | MIF modulators |
BRPI0920354A2 (pt) | 2008-10-16 | 2017-06-27 | Addex Pharmaceuticals Sa | derivados de indol e benzomorfolina como moduladores de receptores de glutamato metabotrópicos |
JP5930278B2 (ja) | 2008-11-25 | 2016-06-08 | ユニバーシティー オブ ロチェスター | Mlk阻害剤および使用方法 |
EP2408753A4 (en) | 2009-03-20 | 2012-11-07 | Univ Brandeis | COMPOUNDS AND METHOD FOR THE TREATMENT OF MICROBIAL STOMACH DARM INFECTIONS IN MAMMALS |
US8906914B2 (en) | 2009-08-18 | 2014-12-09 | Janssen Pharmaceutica Nv | Ethylene diamine modulators of fatty acid hydrolase |
WO2011156245A2 (en) | 2010-06-09 | 2011-12-15 | Merck Sharp & Dohme Corp. | Positive allosteric modulators of mglur2 |
JP5990106B2 (ja) | 2011-01-28 | 2016-09-07 | 佐藤製薬株式会社 | 縮環化合物 |
JP2012188363A (ja) | 2011-03-09 | 2012-10-04 | Dainippon Sumitomo Pharma Co Ltd | アザベンゾイミダゾロン誘導体 |
DK2570415T3 (en) | 2011-09-19 | 2015-11-23 | Sanofi Sa | N- [4- (1H-pyrazolo [3,4-b] pyrazin-6-yl) phenyl] sulfonamides and their use as medicaments |
WO2013060029A1 (en) | 2011-10-28 | 2013-05-02 | Merck Sharp & Dohme Corp | Allosteric modulators of metabotropic glutamate receptors |
US9434743B2 (en) | 2012-03-02 | 2016-09-06 | Takeda Pharmaceutical Company Limited | Indazole derivatives |
MA37975B2 (fr) | 2012-09-11 | 2021-03-31 | Genzyme Corp | Inhibiteurs de synthase de glucosylcéramide |
WO2014124651A1 (en) | 2013-02-15 | 2014-08-21 | Københavns Universitet | Pyrrolidine-2-carboxylic acid derivatives as iglur antagonists |
JP2016516710A (ja) | 2013-03-13 | 2016-06-09 | アッヴィ・インコーポレイテッド | ピリジン系cdk9キナーゼ阻害薬 |
KR102244719B1 (ko) | 2013-03-15 | 2021-04-26 | 플렉시콘 인코퍼레이티드 | 헤테로시클릭 화합물 및 그의 용도 |
AU2014284616B2 (en) * | 2013-06-21 | 2019-02-28 | Zenith Epigenetics Ltd. | Novel bicyclic bromodomain inhibitors |
LT3049417T (lt) | 2013-07-31 | 2019-02-11 | Merck Patent Gmbh | Piridinai, pirimidnai ir pirazinai kaip btk inhibitoriai ir jų panaudojimas |
JP6618525B2 (ja) | 2014-08-15 | 2019-12-11 | ヤンセン ファーマシューティカルズ,インコーポレーテッド | ピラゾール類 |
DK3180329T3 (da) | 2014-08-15 | 2020-04-06 | Janssen Pharmaceuticals Inc | Triazoler som nr2b receptorinhibitorer |
US20170313719A1 (en) | 2014-11-18 | 2017-11-02 | Emory University | Thieno[2,3-D]pyrimidin-4-one Derivatives as NMDAR Modulators and Uses Related Thereto |
MA41803A (fr) | 2015-03-24 | 2018-01-30 | Almirall Sa | Dérivés amino-indazoles utilisés comme inhibiteurs des canaux sodiques |
AU2016255431B2 (en) * | 2015-04-29 | 2020-05-07 | Janssen Pharmaceutica Nv | Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulators |
KR20180026760A (ko) * | 2015-07-09 | 2018-03-13 | 얀센 파마슈티카 엔.브이. | 치환된 4-아자인돌 및 glun2b 수용체 조절제로서의 이의 용도 |
SG11201806750WA (en) | 2016-02-10 | 2018-09-27 | Janssen Pharmaceutica Nv | Substituted 1,2,3-triazoles as nr2b-selective nmda modulators |
TW201819376A (zh) * | 2016-10-06 | 2018-06-01 | 比利時商健生藥品公司 | 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途 |
US11447503B2 (en) | 2019-06-14 | 2022-09-20 | Janssen Pharmaceutica Nv | Pyridine carbamates and their use as GLUN2B receptor modulators |
WO2018231745A1 (en) | 2017-06-14 | 2018-12-20 | Trevena, Inc. | Compounds for modulating s1p1 activity and methods of using the same |
US10766893B2 (en) | 2017-12-20 | 2020-09-08 | H. Lundbeck A/S | 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors |
MA52244A (fr) | 2018-04-04 | 2021-02-17 | Janssen Pharmaceutica Nv | Pyridine et pyrimidines substituées et leur utilisation en tant que modulateurs du récepteur glun2b |
CN110294756A (zh) | 2019-06-04 | 2019-10-01 | 广州市原子高科同位素医药有限公司 | GluN2B亚基靶向型中枢神经系统正电子示踪剂及其制备 |
CN114008052A (zh) | 2019-06-14 | 2022-02-01 | 詹森药业有限公司 | 取代的吡唑并-吡嗪以及它们作为GluN2B受体调节剂的用途 |
EP3983073A1 (en) | 2019-06-14 | 2022-04-20 | Janssen Pharmaceutica NV | Substituted pyrazolo[4,3-b]pyridines and their use as glun2b receptor modulators |
KR20220020915A (ko) | 2019-06-14 | 2022-02-21 | 얀센 파마슈티카 엔.브이. | GluN2B 수용체 조절제로서의 피라진 카르바메이트 및 이들의 용도 |
EP3982958A1 (en) | 2019-06-14 | 2022-04-20 | Janssen Pharmaceutica NV | Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulators |
PE20220386A1 (es) | 2019-06-14 | 2022-03-18 | Janssen Pharmaceutica Nv | Amidas de pirazolo-piridina sustituidas y su uso como moduladores del receptor glun2b |
-
2020
- 2020-06-12 EP EP20733713.0A patent/EP3982958A1/en active Pending
- 2020-06-12 JO JOP/2021/0330A patent/JOP20210330A1/ar unknown
- 2020-06-12 US US16/899,829 patent/US11530210B2/en active Active
- 2020-06-12 WO PCT/EP2020/066384 patent/WO2020249785A1/en unknown
- 2020-06-12 MA MA056183A patent/MA56183A/fr unknown
- 2020-06-12 MX MX2021015503A patent/MX2021015503A/es unknown
- 2020-06-12 CR CR20210615A patent/CR20210615A/es unknown
- 2020-06-12 KR KR1020227001097A patent/KR20220024512A/ko unknown
- 2020-06-12 JP JP2021573899A patent/JP2022536424A/ja active Pending
- 2020-06-12 CA CA3143276A patent/CA3143276A1/en active Pending
- 2020-06-12 AU AU2020291188A patent/AU2020291188A1/en active Pending
- 2020-06-12 BR BR112021025141A patent/BR112021025141A2/pt unknown
- 2020-06-12 TW TW109119836A patent/TW202115054A/zh unknown
- 2020-06-12 CN CN202080043611.8A patent/CN114007610A/zh active Pending
- 2020-06-12 PE PE2021002072A patent/PE20220806A1/es unknown
- 2020-06-12 SG SG11202112405VA patent/SG11202112405VA/en unknown
-
2021
- 2021-12-02 DO DO2021000250A patent/DOP2021000250A/es unknown
- 2021-12-07 CL CL2021003257A patent/CL2021003257A1/es unknown
- 2021-12-09 IL IL288858A patent/IL288858A/en unknown
- 2021-12-13 CO CONC2021/0016860A patent/CO2021016860A2/es unknown
- 2021-12-14 EC ECSENADI202190450A patent/ECSP21090450A/es unknown
-
2022
- 2022-09-12 US US17/942,829 patent/US20230045960A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
SG11202112405VA (en) | 2021-12-30 |
BR112021025141A2 (pt) | 2022-01-25 |
KR20220024512A (ko) | 2022-03-03 |
AU2020291188A1 (en) | 2022-01-20 |
MA56183A (fr) | 2022-04-20 |
WO2020249785A1 (en) | 2020-12-17 |
CO2021016860A2 (es) | 2022-01-17 |
EP3982958A1 (en) | 2022-04-20 |
JP2022536424A (ja) | 2022-08-16 |
PE20220806A1 (es) | 2022-05-20 |
IL288858A (en) | 2022-02-01 |
CL2021003257A1 (es) | 2022-08-19 |
TW202115054A (zh) | 2021-04-16 |
CN114007610A (zh) | 2022-02-01 |
ECSP21090450A (es) | 2022-01-31 |
US20230045960A1 (en) | 2023-02-16 |
CR20210615A (es) | 2022-01-31 |
CA3143276A1 (en) | 2020-12-17 |
US20210017169A1 (en) | 2021-01-21 |
MX2021015503A (es) | 2022-04-20 |
DOP2021000250A (es) | 2022-03-31 |
US11530210B2 (en) | 2022-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20210615A (es) | Pirazolo piridinas heteroaromáticas sustituidas y su uso como moduladores del receptor glun2b | |
MX2018009752A (es) | 1,2,3,-triazoles sustituidos como moduladores de nmda selectivos de nr2b. | |
MX2021015500A (es) | Pirazolo-pirazinas sustituidas y su uso como moduladores del receptor glun2b. | |
MX2021005887A (es) | Compuestos de 2-formil-3-hidroxifeniloximetilo capaces de modular hemoglobina. | |
JOP20210328A1 (ar) | مركبات أميدات بيريدين-بيرازولو المستبدلة واستخدامها باعتبارها معدِّلات لمستقبل الغلوتومات "glun2b" | |
MX2018000352A (es) | 4-azaindoles sustituidos y su uso como moduladores del receptor glun2b. | |
AU2018260809A1 (en) | Compounds and uses thereof for the modulation of hemoglobin | |
AU2018260808A1 (en) | Compounds and uses thereof for the modulation of hemoglobin | |
EA201990848A1 (ru) | ЗАМЕЩЕННЫЕ 1H-ИМИДАЗО[4,5-b]ПИРИДИН-2(3H)-ОНЫ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ РЕЦЕПТОРА GLUN2B | |
SG10201808053XA (en) | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders | |
MX2019000588A (es) | Moduladores de la somatostatina y usos de los mismos. | |
MX2021015510A (es) | Pirazolo[4,3-b]piridinas sustituidas y su uso como moduladores del receptor glun2b. | |
NZ737399A (en) | Ccr2 modulators | |
EA201591403A1 (ru) | Спиролактамные модуляторы рецептора nmda и их применение | |
MX2019010949A (es) | Moduladores de somatostatina y usos de los mismos. | |
WO2019193516A3 (en) | Substituted pyridine and pyrimidines and their use as glun2b receptor modulators | |
PH12020551144A1 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
MX2021015508A (es) | Carbamatos de piridina y su uso como moduladores del receptor glun2b. | |
MX2020008106A (es) | Moduladores del receptor nmda espiro-lactama y usos de los mismos. | |
MX2022001874A (es) | Receptores agonistas no peptidicos de somatostatina tipo 5 y usos de los mismos. | |
MX2021015511A (es) | Carbamatos de pirazina y sus usos como moduladores del receptor glun2b. | |
MX2020007586A (es) | Proceso de fabricacion de moduladores de somatostatina. | |
MX2021002916A (es) | Pirfenidona enriquecida con deuterio y métodos para su uso. | |
WO2020106461A3 (en) | Anti-mertk antibodies and methods of use thereof | |
EP4219507A3 (en) | Thienopyrimidinone nmda receptor modulators and uses thereof |